Gainers
Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.
Piper Sandler analyst Paul Newsome upgrades Universal Insurance Hldgs (NYSE:UVE) from Neutral to Overweight and raises the price target from $11 to $19.